108 related articles for article (PubMed ID: 26310520)
1. Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Bröckelmann PJ; Goergen H; Fuchs M; Kriz J; Semrau R; Baues C; Kobe C; Behringer K; Eichenauer DA; von Tresckow B; Klimm B; Halbsguth T; Wongso D; Plütschow A; Haverkamp H; Dietlein M; Eich HT; Stein H; Diehl V; Borchmann P; Engert A
Br J Haematol; 2015 Nov; 171(4):547-56. PubMed ID: 26310520
[TBL] [Abstract][Full Text] [Related]
2. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group.
Klimm B; Franklin J; Stein H; Eichenauer DA; Haverkamp H; Diehl V; Fuchs M; Borchmann P; Engert A
J Clin Oncol; 2011 Oct; 29(29):3914-20. PubMed ID: 21911729
[TBL] [Abstract][Full Text] [Related]
4. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
[TBL] [Abstract][Full Text] [Related]
5. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin lymphoma: clinicopathologic features in Benin City, Nigeria and update on its biology and classification.
Olu-Eddo AN; Omoti CE
Niger J Clin Pract; 2011; 14(4):440-4. PubMed ID: 22248946
[TBL] [Abstract][Full Text] [Related]
7. Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).
Kriz J; Baues C; Engenhart-Cabillic R; Haverkamp U; Herfart K; Lukas P; Plütschow A; Schmidberger H; Staar S; Fuchs M; Engert A; Eich HT
Strahlenther Onkol; 2017 Feb; 193(2):109-115. PubMed ID: 27596217
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
[TBL] [Abstract][Full Text] [Related]
9. Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma.
Baues C; Görgen H; Semrau R; Nast-Kolb B; Assenmacher K; Celik E; Morgenthaler J; Rosenbrock J; Trommer M; Houbois C; Kobe C; Kriz J; Engert A; Marnitz S
Leuk Lymphoma; 2019 Dec; 60(13):3244-3250. PubMed ID: 31232136
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.
Eichenauer DA; Plütschow A; Fuchs M; von Tresckow B; Böll B; Behringer K; Diehl V; Eich HT; Borchmann P; Engert A
J Clin Oncol; 2015 Sep; 33(26):2857-62. PubMed ID: 26240235
[TBL] [Abstract][Full Text] [Related]
11. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
Behringer K; Goergen H; Müller H; Thielen I; Brillant C; Kreissl S; Halbsguth TV; Meissner J; Greil R; Moosmann P; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2016 Dec; 34(36):4329-4337. PubMed ID: 27998235
[TBL] [Abstract][Full Text] [Related]
14. Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
Kreissl S; Müller H; Goergen H; Meissner J; Topp M; Sökler M; Markova J; Bernhard J; Greil R; von Tresckow B; Behringer K; Rüffer JU; Flechtner HH; Möstl M; Fuchs M; Engert A; Diehl V; Borchmann P
J Clin Oncol; 2020 Sep; 38(25):2839-2848. PubMed ID: 32574114
[TBL] [Abstract][Full Text] [Related]
15. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
16. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and prognostic factors of 62 cases with Hodgkin lymphoma].
Wan WL; Tian L; Wang J; Zhang W; Jing HM; Wang JJ; Liu Y; Hou SL; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):618-21. PubMed ID: 23906458
[TBL] [Abstract][Full Text] [Related]
18. Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
Giulino-Roth L; Keller FG; Hodgson DC; Kelly KM
Br J Haematol; 2015 Jun; 169(5):647-60. PubMed ID: 25824371
[TBL] [Abstract][Full Text] [Related]
19. First-line treatment of Hodgkin's lymphoma.
Klimm B; Engert A; Diehl V
Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
